PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(13 sites)

United States

Research Site, Washington D.C., District of Columbia

Research Site, Norfolk, Virginia

Brazil

Research Site, Joinville

Research Site, Salvador

Research Site, São José do Rio Preto

Research Site, São Paulo

Japan

Research Site, Saitama-Shi

Poland

Research Site, Bydgoszcz

Research Site, Lodz

Research Site, Warsaw

Taiwan

Research Site, New Taipei City

Research Site, Taipei